Gene Editing Cannot Be Separated From The Violent History of Eugenics and Medical Racism
By Jude Casimir,
Wear Your Voice [cites CGS' Marcy Darnovsky]
| 10. 27. 2020
Henrietta Lacks visited John Hopkins Hospital in 1951, complaining of vaginal bleeding. A mother of five children, Lacks was diagnosed by gynecologist Howard Jones with cervical cancer. After undergoing radium treatments, sample cells were extracted from her tumor. While the cells extracted from other patients suffering the same illness swiftly withered and died, those extracted from Lacks lived on. Not only did they live, they doubled at an incredible rate—in 20 to 24 hours.
Now known as “HeLa” cells, this tissue was used to study a variety of bodily issues, becoming the basis for a large number of medical advancements throughout the 20th century. Lacks died on October 4, 1951, at the age of 31, just over nine months after she visited John Hopkins Hospital and having never consented to the use of her cervical cells.
While a case brought before the Supreme Court of California—Moore v. Regents of the University of California (1990)—ultimately ruled that discarded cells are not the property of the person from whose body they originate, the case of Henrietta Lacks still haunts the question of gene...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...